The latest trending report published by Crystal Market Research titled, Obesity Treatment Market, approximates that the Obesity Treatment industry size is estimated to flourish at a significant CAGR in the future, and this is attributed to the escalation in need for this product across the globe along with novel innovations in the market.
Obesity Treatment Market is expected to experience an average growth in coming years between 2017 and 2025. The market is expected to become $0.81 billion by 2025 at a slow CAGR of 4.72%. The technological advancement to improve compliance rates of surgeries, Government initiatives to increase awareness about fitness among people and aggressive promotional activities to attract customers will be the major driving factors of obesity treatment market. Obesity has become a common phenomenon across the globe in all age groups. For instance, as per survey, in US, adult obesity rates has exceeded more than 34% in five states, more than 28% in 26 states and more than 22% in 48 states in 2016.
Get Sample Copy of the Report here: https://www.crystalmarketresearch.com/report-sample/HC06102
Scope of the Report:
North America held a significant share of the obesity treatment market in 2016 due to the increase in obesity cases in various states. In addition, increase in disposable income has also led to more adoption of obesity treatment by people. The Asia-Pacific market has not experienced any substantial growth due to lack of large scale adoption of advanced treatment for obesity management but can experience favorable growth in coming years owing to increasing awareness and changing lifestyles related to obesity management in the region.
Key Players Operating In Global Market:
The key players operating in the global obesity treatment market emphasize on product development in order to introduce improve obesity treatment and capture a larger share of the market. Some of the major players in this market are, Allergan Plc, Medtronic, VIVUS, Inc., Atkins Nutritionals, Inc., EnteroMedics, Inc, F. Hoffmann-La Roche Ltd., Apollo Endosurgery, Inc., Novo Nordisk A/S, USGI Medical, Inc., Ethicon (subsidiary of Johnson & Johnson), Herbalife Ltd., Cousin Biotech, Johnson Health Technology, Ltd., Orexigen Therapeutics, and Technogym Spa.
Global Obesity Treatment Market Segmentation:
By Devices and Surgery
Roux-en-Y Gastric Bypass
Biliopancreatic Diversion with Duodenal Switch
Adjusting Gastric Banding
Speak to Experts for any Queries: https://www.crystalmarketresearch.com/send-an-enquiry/HC06102
About Crystal Market Research:
Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
Toll Free: +1-888-213-4282
Author: Chris-HarrisThis author has published 13 articles so far. More info about the author is coming soon.